
---
title: "1273 BMY"
subtitle: "Stock Analysis by ChatGPT"
date: 2023-08-06T12:13:03
draft: true
tags: ['Bristol-Myers Squibb Company', 'BMY', 'Pharmaceuticals', 'Q2 Earnings', 'Generic Erosion']
author: Friday Wall
---

score:1273
### Chances:
1. Institutions' substantial holdings in Bristol-Myers Squibb imply significant influence on the stock.
2. Merck's stronger-than-expected second-quarter earnings may signal positive prospects for the pharmaceutical sector.
3. Bristol-Myers Squibb's earnings and revenue surprises for Q2 2023 could provide insights into the stock's future performance.
4. Pfizer's mixed second-quarter earnings may impact the pharmaceutical industry amid uncertainty around COVID.
5. Qualcomm's downgrade and Wingstop's upgrade by Wall Street's top analyst could influence investor sentiment in the sector.
6. Attractively valued corporations like Bristol Myers Squibb and Pfizer may present investment opportunities.
7. Howard Marks' perspective on share price volatility may apply to Bristol-Myers Squibb's stock.
8. Crocs stock's fall and AbbVie's better-than-expected Q2 sales of arthritis medication Humira could offer industry insights.
9. Giovanni Caforio, CEO of Bristol-Myers Squibb, presented second-quarter results, including a sales miss for the oncology drug Revlimid.
### Risks:
1. Bristol-Myers Squibb's sales shortfall and reduced financial outlook due to generic erosion for Revlimid may impact future performance.
2. Lower-than-expected sales of cancer-fighting drugs Revlimid and Pomalyst affected Bristol-Myers Squibb's second-quarter results.
3. Slow, sometimes nonexistent, revenue growth in past quarters has affected Bristol Myers Squibb's stock performance.
4. Competition from generic alternatives has been hurting Bristol-Myers Squibb's sales figures.
5. Uncertainty around COVID remains a headwind for Pfizer's second-quarter earnings.
6. Bristol-Myers Squibb's Q2 earnings and revenue surprises of -12.06% and 4.96% could affect investor sentiment.
7. The company's cuts to its 2023 forecast may raise concerns about Bristol-Myers Squibb's future outlook.
### Score:1273
chances characters count - risks characters count = 273

investment score = 1000 + chances characters count - risks characters count
### References:
- 2023-08-06 [Bristol-Myers Squibb Company (NYSE:BMY) is favoured by institutional owners who hold 78% of the company](https://finance.yahoo.com/news/bristol-myers-squibb-company-nyse-120045924.html?.tsrc=rss)
- 2023-08-03 [Qualcomm downgraded, Wingstop upgraded: Wall Street's top analyst calls](https://finance.yahoo.com/news/qualcomm-downgraded-wingstop-upgraded-wall-140329294.html?.tsrc=rss)
- 2023-08-03 [Here's Why Investors Should Buy These 2 Medical Stocks After Earnings](https://finance.yahoo.com/news/heres-why-investors-buy-2-053100534.html?.tsrc=rss)
- 2023-08-02 [Pfizer reports mixed quarterly results on uncertain COVID outlook](https://finance.yahoo.com/news/pfizer-reports-mixed-quarterly-results-on-uncertain-covid-outlook-191025365.html?.tsrc=rss)
- 2023-08-02 [Merck upgrades guidance on stronger 2023 outlook as COVID business declines](https://finance.yahoo.com/news/merck-upgrades-guidance-on-stronger-2023-outlook-as-covid-business-declines-182600017.html?.tsrc=rss)
- 2023-07-31 [These 4 Measures Indicate That Bristol-Myers Squibb (NYSE:BMY) Is Using Debt Reasonably Well](https://finance.yahoo.com/news/4-measures-indicate-bristol-myers-110024578.html?.tsrc=rss)
- 2023-07-28 [Bristol Myers Squibb (BMY) Q2 2023 Earnings Call Transcript](https://finance.yahoo.com/m/ec34ff23-91bf-31e3-a659-b33e851ff698/bristol-myers-squibb-%28bmy%29-q2.html?.tsrc=rss)
- 2023-07-28 [Bristol-Myers (BMY) Q2 Earnings, Sales Miss, '23 View Lowered](https://finance.yahoo.com/news/bristol-myers-bmy-q2-earnings-175500502.html?.tsrc=rss)
- 2023-07-28 [Bristol Myers Slashes Forecast on Tumbling Revlimid Sales](https://finance.yahoo.com/m/974be2e8-5c39-3e74-abfd-45c04fe83685/bristol-myers-slashes.html?.tsrc=rss)
- 2023-07-27 [Crocs record revenue, AbbVie's Humira sales, Bristol-Myers competition: Top stocks](https://finance.yahoo.com/video/crocs-record-revenue-abbvies-humira-144233709.html?.tsrc=rss)


                